Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.65 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.35 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.35 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.35 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.35 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexanone SCHEMBL8679167 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL4903664 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2196651 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2197202 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL17629439 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2193717 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL9355151 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL1472595 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2197197 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL110906 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1573 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | claimed |
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| US-12421474-B2 | Perfume oil mixture | SYMRISE AG (DE) | 2025-09-23 | — | — | US | claimed |
| US-20250188501-A1 | SEMISYNTHETIC ROUTES TO ORGANIC COMPOUNDS | AGAIN BIO APS (DK) | 2025-06-12 | — | — | US | claimed |
| US-12290591-B2 | Fragrance compositions | FIRMENICH SA (CH) | 2025-05-06 | — | — | US | claimed |
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| CN-119403908-A | Method for enhancing psychological performance and composition for use in the method | 弗门尼舍有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-113784759-B | Fragrance composition | 弗门尼舍有限公司 | 2024-07-05 | — | — | CN | claimed |
| US-20240197243-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| US-6590048-B1 | Catalysts comprising group VIII compounds used for cyclization of crown ethers, antibiotics, veterinary medicines or perfumes | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2003-07-08 | — | — | US | claimed |
| EP-1037897-B1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-06-12 | — | — | EP | claimed |
| US-20020068717-A1 | Methods and compositions for enhancing diffusion of therapeutic agents through tissue | WILLIAM BEAUMONT HOSPITAL | 2002-06-06 | — | — | US | claimed |
| US-6379658-B1 | CONSISTING OF BETA-NAPHTHYL METHYL ETHER, BETA-NAPHTHYL KETONE, BENZYL ACETONE, HEXAHYDRO-4,7-METHANOINDEN-5-YL AND 6-YL PROPIONATES, GAMMA-METHYL IONONE, FURAN DERIVATIVE, 3,7-DIMETHYL-2,6-NONADIEN-1-NITRILE, CYCLIC ESTER, KETONE | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2002-04-30 | — | — | US | claimed |
| EP-1113105-A2 | Human sweat malodor counteractant composition and process for using same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2001-07-04 | — | — | EP | claimed |
| EP-1037897-A1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | Studiengesellschaft Kohle mbH (DE) | 2000-09-27 | — | — | EP | claimed |
| WO-1999028330-A1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1999-06-10 | — | — | WO | claimed |
| EP-0921129-A1 | Highly active cationic ruthenium and osmium complexes for olefin metathesis reactions | Studiengesellschaft Kohle mbH (DE) | 1999-06-09 | — | — | EP | claimed |
| US-5641847-A | DEODORIZING THE ROOM SPACE USING A CROSSLINKED HOMO- OR COACRYLIC POLYMER ABSORBANT RETAINING AROMATIC PERFUME | NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JP) | 1997-06-24 | — | — | US | claimed |
| US-5120709-A | Applying a solution of one or more fixative agents separately | NEUROSCENTS, INC. (US) | 1992-06-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | TRIM24 1669/4885TRIM33 3601/4885ALDH1A1 205/4885 |
| US-20020068717-A1 | Methods and compositions for enhancing diffusion of therapeutic agents through tissue | TK1, TK2, DNASE1 | TRIM24 1392/4885TRIM33 3243/4885ALDH1A1 2369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.